Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × apatinib × Clear all

NCT06764368 2025-01-08

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

Phase 2 Not yet recruiting

Neuroendocrine Tumors